NCT04824729View on ClinicalTrials.gov

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients

CompletedOBSERVATIONAL
Enrollment

227,613

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

January 7, 2022

Study Completion Date

January 7, 2022

Conditions
Peripheral Artery Disease
Interventions
PROCEDURE

Lower limb revascularization

French population of patients with lower-extremity peripheral artery disease who have undergone lower limb revascularization.

PROCEDURE

Lower limb revascularization

French population of patients matching the VOYAGER PAD exclusion criteria resembling a subgroup of the PAD revascularized population.

Trial Locations (1)

Unknown

PMSI, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

External supplier: HEVA

UNKNOWN

lead

Bayer

INDUSTRY

NCT04824729 - A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients | Biotech Hunter | Biotech Hunter